Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs
Giuseppe Patti(University of L'Aquila), Paola Simeone(University of Chieti-Pescara), Vittorio Pengo(University of Padua), Domenico Prisco(University of Florence), Vito Maurizio Parato(Marche Polytechnic University), Gentian Denas(University of Padua), Mattía Galli(Maria Cecilia Hospital), Elisabetta Ricottini(Università Campus Bio-Medico), Ilaria Cavallari(Università Campus Bio-Medico), Rossella Marcucci(Azienda Ospedaliero-Universitaria Careggi), Raffaele De Caterina(Brigham and Women's Hospital), Plinio Cirillo(Federico II University Hospital), Giulia Renda(University of Chieti-Pescara), Francesca Santilli(University of Chieti-Pescara), Enrica Golia(University of Campania "Luigi Vanvitelli"), Ernesto Maddaloni(Università Campus Bio-Medico), Paolo Calabrò(University of Campania "Luigi Vanvitelli"), Felicita Andreotti
Cited by 116
Related Papers
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)
|European Heart Journal|2010|2.3k
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k
Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.
|Journal of Clinical Investigation|1995|1.8k